Literature DB >> 19903733

Effects of baclofen on motor units paralysed by chronic cervical spinal cord injury.

Christine K Thomas1, Charlotte K Häger-Ross, Cliff S Klein.   

Abstract

Baclofen, a gamma-aminobutyric acid receptor(B) agonist, is used to reduce symptoms of spasticity (hyperreflexia, increases in muscle tone, involuntary muscle activity), but the long-term effects of sustained baclofen use on skeletal muscle properties are unclear. The aim of our study was to evaluate whether baclofen use and paralysis due to cervical spinal cord injury change the contractile properties of human thenar motor units more than paralysis alone. Evoked electromyographic activity and force were recorded in response to intraneural stimulation of single motor axons to thenar motor units. Data from three groups of motor units were compared: 23 paralysed units from spinal cord injured subjects who take baclofen and have done so for a median of 7 years, 25 paralysed units from spinal cord injured subjects who do not take baclofen (median: 10 years) and 45 units from uninjured control subjects. Paralysed motor unit properties were independent of injury duration and level. With paralysis and baclofen, the median motor unit tetanic forces were significantly weaker, twitch half-relaxation times longer and half maximal forces reached at lower frequencies than for units from uninjured subjects. The median values for these same parameters after paralysis alone were comparable to control data. Axon conduction velocities differed across groups and were slowest for paralysed units from subjects who were not taking baclofen and fastest for units from the uninjured. Greater motor unit weakness with long-term baclofen use and paralysis will make the whole muscle weaker and more fatigable. Significantly more paralysed motor units need to be excited during patterned electrical stimulation to produce any given force over time. The short-term benefits of baclofen on spasticity (e.g. management of muscle spasms that may otherwise hinder movement or social interactions) therefore have to be considered in relation to its possible long-term effects on muscle rehabilitation. Restoring the strength and speed of paralysed muscles to pre-injury levels may require more extensive therapy when baclofen is used chronically.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903733      PMCID: PMC2857957          DOI: 10.1093/brain/awp285

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  59 in total

1.  GABAB receptors in Schwann cells influence proliferation and myelin protein expression.

Authors:  Valerio Magnaghi; Marinella Ballabio; Ilaria T R Cavarretta; Wolfgang Froestl; Jeremy J Lambert; Ileana Zucchi; Roberto C Melcangi
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

2.  The effect of prolonged inactivity upon the contraction characteristics of fast and slow mammalian twitch muscle.

Authors:  C J Davis; A Montgomery
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

3.  The action of a GABA derivative in human spasticity.

Authors:  D Burke; C J Andrews; L Knowles
Journal:  J Neurol Sci       Date:  1971-10       Impact factor: 3.181

4.  Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba).

Authors:  E Pedersen; P Arlien-Soborg; V Grynderup; O Henriksen
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

5.  Long-term effects of spinal cord transection on fast and slow rat skeletal muscle. I. Contractile properties.

Authors:  R L Lieber; C B Johansson; H L Vahlsing; A R Hargens; E R Feringa
Journal:  Exp Neurol       Date:  1986-03       Impact factor: 5.330

6.  EMG activity of slow and fast ankle extensors following spinal cord transection.

Authors:  M A Alaimo; J L Smith; R R Roy; V R Edgerton
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-06

7.  Fatigue of paralyzed and control thenar muscles induced by variable or constant frequency stimulation.

Authors:  Christine K Thomas; Lisa Griffin; Sharlene Godfrey; Edith Ribot-Ciscar; Jane E Butler
Journal:  J Neurophysiol       Date:  2002-12-11       Impact factor: 2.714

8.  Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity.

Authors:  Y Li; X Li; P J Harvey; D J Bennett
Journal:  J Neurophysiol       Date:  2004-11       Impact factor: 2.714

9.  Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord?

Authors:  G W Price; G P Wilkin; M J Turnbull; N G Bowery
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

10.  Physiological types and histochemical profiles in motor units of the cat gastrocnemius.

Authors:  R E Burke; D N Levine; P Tsairis; F E Zajac
Journal:  J Physiol       Date:  1973-11       Impact factor: 5.182

View more
  18 in total

1.  Firing patterns of spontaneously active motor units in spinal cord-injured subjects.

Authors:  Inge Zijdewind; Christine K Thomas
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

2.  Subcortical control of precision grip after human spinal cord injury.

Authors:  Karen L Bunday; Toshiki Tazoe; John C Rothwell; Monica A Perez
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

3.  Repeated and patterned stimulation of cutaneous reflex pathways amplifies spinal cord excitability.

Authors:  Gregory E P Pearcey; E Paul Zehr
Journal:  J Neurophysiol       Date:  2020-06-24       Impact factor: 2.714

4.  Selective effects of baclofen on use-dependent modulation of GABAB inhibition after tetraplegia.

Authors:  Melissa D Barry; Karen L Bunday; Robert Chen; Monica A Perez
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

5.  Resolution of Enantiomers of (RS)-Baclofen by Ligand-Exchange Thin-Layer Chromatography.

Authors:  Manisha Singh; Poonam Malik; Ravi Bhushan
Journal:  J Chromatogr Sci       Date:  2016-02-18       Impact factor: 1.618

6.  Imbalanced Corticospinal and Reticulospinal Contributions to Spasticity in Humans with Spinal Cord Injury.

Authors:  Sina Sangari; Monica A Perez
Journal:  J Neurosci       Date:  2019-08-14       Impact factor: 6.167

Review 7.  Strategies to augment volitional and reflex function may improve locomotor capacity following incomplete spinal cord injury.

Authors:  Kristan A Leech; Hyosub E Kim; T George Hornby
Journal:  J Neurophysiol       Date:  2017-11-01       Impact factor: 2.714

Review 8.  Rehabilitation Strategies after Spinal Cord Injury: Inquiry into the Mechanisms of Success and Failure.

Authors:  Marie-Pascale Côté; Marion Murray; Michel A Lemay
Journal:  J Neurotrauma       Date:  2016-11-21       Impact factor: 5.269

9.  Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study.

Authors:  Kaila A Holtz; Elena Szefer; Vanessa K Noonan; Brian K Kwon; Patricia B Mills
Journal:  Spinal Cord       Date:  2018-06-14       Impact factor: 2.772

10.  The experience of spasticity after spinal cord injury: perceived characteristics and impact on daily life.

Authors:  William Barry McKay; William Mark Sweatman; Edelle C Field-Fote
Journal:  Spinal Cord       Date:  2018-01-16       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.